Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
Human Gene Therapy|February 22, 2024
Current Status and Prospects of Viral Vector-Based Gene Therapy to Treat Kidney DiseasesLouise Medaer, Koenraad Veys, Rik GijsbersJournal of Inherited Metabolic Disease|September 8, 2021
Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testisAhmed Reda, Koenraad Veys, Prashant Kadam, et al.JIMD Reports|December 8, 2017
Effect of Storage Conditions on Stability of Ophthalmological Compounded Cysteamine Eye DropsAhmed Reda, Ann Van Schepdael, Erwin Adams, et al.Drug Discovery Today|February 19, 2013
Cysteamine: an old drug with new potentialMartine Besouw, Rosalinde Masereeuw, Lambert van den Heuvel, et al.Molecular Genetics and Metabolism|July 27, 2012
Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrateMartine Besouw, Albert Tangerman, Elisabeth Cornelissen, et al.Ophthalmology and Therapy|September 28, 2019
Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective AnalysisFreya Peeters, Catherine Cassiman, Karel Van Keer, et al.Ultrasound (Leeds, England)|February 16, 2023
OHVIRA syndrome: Early recognition prevents genitourinary complicationsAnne Sijmons, Suzanne Broekhuizen, Karin van der Tuuk, et al.Molecular Genetics and Metabolism|May 22, 2007
The origin of halitosis in cystinotic patients due to cysteamine treatmentMartine Besouw, Henk Blom, Albert Tangerman, et al.Journal of Inherited Metabolic Disease|September 18, 2022
Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort studyKoenraad Veys, Ward Zadora, Katharina Hohenfellner, et al.Pageof 14